Moderna (MRNA) Cost of Revenue (2020 - 2026)
Moderna (MRNA) recorded Cost of Revenue of $93 million in Q2 2026, down 21.8% from $119 million a year earlier and down 90.3% from the prior quarter.
Moderna (MRNA) Cost of Revenue (2020 - 2026) Analysis & Trends
On a TTM basis, Moderna's Cost of Revenue came in at $1.71 billion as of Jun 30, 2026, up 16.8% year-over-year; for FY2025, it was $868 million, down 40.7% from FY2024.
- Annual Cost of Revenue has declined for three straight years, though with a five-year compound annual growth rate of 155.3% (FY2020 to FY2025).
- Across earlier years, Cost of Revenue came in at $1.46 billion in FY2024 (-68.8%), $4.69 billion in FY2023 (-13.3%), $5.42 billion in FY2022 (+107.0%) and $2.62 billion in FY2021.
- The Q2 2026 figure is the lowest quarterly Cost of Revenue since Q1 2025.
- On a year-over-year basis, Cost of Revenue rose in two of the last eight quarters, with growth averaging 92.6%.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 961.1% in Q1 2026, against a decline of 87.9% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $955 million (Q1 2026), $452 million (Q4 2025) and $207 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn | 93.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.00 Mn |
| Mar 31, 2026 | 955.00 Mn |
| Dec 31, 2025 | 452.00 Mn |
| Sep 30, 2025 | 207.00 Mn |
| Jun 30, 2025 | 119.00 Mn |
| Mar 31, 2025 | 90.00 Mn |
| Dec 31, 2024 | 739.00 Mn |
| Sep 30, 2024 | 514.00 Mn |
| Jun 30, 2024 | 115.00 Mn |
| Mar 31, 2024 | 96.00 Mn |
| Dec 31, 2023 | 929.00 Mn |
| Sep 30, 2023 | 2.24 Bn |
| Jun 30, 2023 | 731.00 Mn |
| Mar 31, 2023 | 792.00 Mn |
| Dec 31, 2022 | 1.92 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.38 Bn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 952.00 Mn |
| Sep 30, 2021 | 722.00 Mn |
Moderna Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();